recogn
infect
neoplast
cell
respond
target
lysi
product
cytokin
prolifer
divers
set
effector
function
gener
contribut
clearanc
infect
also
lead
immunopatholog
circul
lymphocyt
deriv
specif
highli
variabl
clonal
distribut
receptor
tcr
inspect
class
major
histocompat
complex
mhc
glycoprotein
composit
surfac
survey
molecul
consist
intracellularli
deriv
antigen
peptid
ligand
present
protein
heterodim
compris
mhc
heavi
chain
well
invari
microglobulin
light
chain
human
class
gene
product
human
leukocyt
antigen
hla
famili
restrict
element
classic
transplant
antigen
encod
three
separ
loci
ie
highli
polymorph
hla
variabl
geograph
distribut
significantli
correl
allel
variant
mark
distinct
ethnic
group
consequ
host
ethnic
shape
fine
specif
reactiv
sever
viral
afflict
ebv
hepat
b
hbv
hcv
hiv
monitor
immun
respons
mhc
multim
reagent
success
exploit
identif
enumer
phenotyp
character
isol
cell
sever
methodolog
emerg
manag
variabl
affect
mhc
antigen
present
enabl
multiparametr
analysi
respons
combinatori
code
mhc
multim
exampl
allow
parallel
detect
multipl
specif
use
limit
number
fluorochrom
flow
cytometri
anoth
technolog
breakthrough
came
develop
condit
ligand
hla
complex
murin
mhc
facilit
product
reagent
divers
specif
common
precursor
strategi
origin
reagent
design
archetyp
later
expand
b
well
b
therebi
provid
signific
coverag
western
european
popul
half
world
popul
howev
inhabit
region
within
asia
oceania
origin
world
popul
data
sheet
http
paradox
accur
definit
epitop
asian
hla
variant
long
trail
european
counterpart
therefor
report
technolog
seven
five
four
restrict
element
commonli
associ
asian
ancestri
enabl
comprehens
assess
correspond
respons
demonstr
util
diagnost
reagent
precis
definit
novel
antigen
deriv
infecti
agent
dengu
viru
denv
sever
acut
respiratori
syndrom
coronaviru
hbv
relev
south
east
asian
sea
popul
discoveri
pipelin
compris
initi
immunosorb
spot
elispot
screen
pool
overlap
peptid
cage
hla
complex
subsequ
facilit
rapid
determin
peptid
fine
specif
hla
restrict
thu
allevi
epitop
discoveri
bottleneck
conserv
pbmc
sampl
process
retrospect
assess
screen
demonstr
major
epitop
would
discov
select
restrict
element
antigen
protein
consid
bioinformat
select
peptid
appli
restrict
commonli
impos
condit
ligand
introduc
toeb
et
al
sensit
acid
group
anp
j
incorpor
peptid
uv
exposur
trigger
photolysi
anp
residu
result
fragment
ligand
affect
amino
acid
complex
sever
design
publish
variabl
motif
often
prohibit
interchang
use
hla
product
aim
develop
condit
ligand
princip
sea
variant
consist
cover
major
molecul
allel
frequenc
asia
fig
neglig
occurr
caucasian
fact
b
c
c
domin
sea
popul
allel
frequenc
least
higher
europ
select
parent
peptid
support
inform
tabl
pertin
hla
strateg
amino
acid
substitut
aim
gener
ligand
unperturb
hla
affin
sever
design
test
fig
support
inform
fig
anp
introduct
central
posit
peptid
endeavor
effect
liber
cleft
fragment
synthesi
ident
condit
ligand
ascertain
lcm
analysi
support
inform
fig
peptid
subsequ
refold
correspond
heavi
light
chain
biotinyl
purifi
chromatographi
produc
hla
monom
although
compar
yield
contenti
refold
concern
distinct
molecular
complex
sever
trend
discern
exampl
product
averag
yield
approxim
mgl
outperform
furnish
approxim
mgl
variat
could
high
hla
product
provid
highest
mgl
mgl
lowest
yield
presum
reflect
differ
ligand
affin
well
overal
stabil
complex
analog
design
parent
peptid
differ
could
observ
mgl
mgml
highest
yield
condit
ligand
hla
select
follow
experi
fig
condit
ligand
permit
manipul
hla
peptid
cargo
exploit
defin
hla
restrict
peptid
novel
epitop
see
without
consum
valuabl
peripher
blood
mononuclear
cell
pbmc
sampl
evalu
structur
integr
hla
complex
monitor
presenc
noncoval
associ
subunit
vitro
elisa
allow
us
verifi
extent
hla
disintegr
variou
stage
photocleavag
reaction
indic
effect
peptid
exchang
pertin
hla
appreci
degrad
condit
complex
observ
absenc
uv
irradi
fig
exposur
uv
light
result
loss
signal
major
hla
product
examin
howev
c
c
display
except
stabil
still
present
cleavag
fig
reminisc
product
yield
complex
fig
uv
fragment
unfold
aggreg
precipit
complex
could
prevent
inclus
peptid
capabl
reoccupi
groov
thu
confer
stabil
deliv
novel
specif
process
antigen
deriv
ebv
human
cytomegaloviru
hbv
denv
influenza
viru
conform
report
restrict
element
restor
complex
least
two
separ
ligand
prove
feasibl
individu
exchang
reaction
fig
support
inform
tabl
howev
peptid
lack
proper
complementar
fail
rescu
hla
uv
irradi
especi
mismatch
hla
supertyp
exampl
clgglltmv
restrict
ie
supertyp
prove
unabl
conserv
integr
b
hla
micropolymorph
also
affect
peptid
bind
flltkilti
glsryvarl
associ
well
prove
capabl
stabil
close
relat
variant
fig
collect
demonstr
success
temporari
stabil
use
condit
ligand
tailor
asian
hla
variant
although
empti
hla
product
could
rescu
decay
question
remain
whether
result
complex
present
antigen
cargo
indistinguish
natur
load
hla
address
stain
popul
asian
hla
tetram
recruit
healthi
volunt
genotyp
allel
support
inform
tabl
fluoresc
label
hla
tetram
ebv
human
cytomegaloviru
hbv
denv
influenza
viru
epitop
gener
support
inform
tabl
tetram
use
direct
ex
vivo
stain
fresh
pbmc
healthi
volunt
donor
respond
ebv
epitop
gqggsptam
flow
analysi
ex
vivo
isol
cell
reveal
major
sampl
detect
respons
support
inform
fig
b
except
distinct
avfdrksdak
tetram
posit
popul
total
cell
therefor
enrich
cell
vitro
cultur
day
follow
antigen
stimul
amplif
allow
visual
cell
hla
tetram
day
support
inform
fig
propag
lymphocyt
success
visual
b
b
b
tetram
repres
signific
proport
averag
cell
well
separ
princip
popul
fig
first
observ
day
poststimul
tetram
could
also
detect
b
tetram
moreov
subject
restrict
cell
engin
tcr
gene
transfer
stain
tetram
load
hbv
core
peptid
evalu
capac
tcr
discrimin
micropolymorph
subtyp
common
sea
popul
fig
recognit
observ
present
hbv
peptid
yet
posit
stain
obtain
tetram
dearth
known
epitop
asian
hla
variant
preclud
confirm
tetram
function
respons
similarli
absent
donor
cohort
valid
hla
tetram
librari
employ
antigen
identif
epitop
asian
variant
scarc
compar
caucasian
counterpart
often
fulli
character
regard
fine
specif
hla
restrict
screen
respons
individu
histori
acut
hbv
exposur
denv
pbmc
vitro
stimul
peptid
pool
overlap
ten
amino
acid
thu
cover
entir
viral
proteom
peptid
hbv
genotyp
b
peptid
np
peptid
protein
peptid
secret
first
assess
elispot
posit
pool
deconvolut
stimul
pbmc
individu
peptid
follow
measur
product
intracellular
cytokin
stain
identifi
novel
respons
deriv
hbv
polymeras
denv
nonstructur
protein
summar
fig
togeth
antigen
embed
nucleocapsid
protein
base
hla
genotyp
line
support
inform
tabl
motif
anticip
restrict
element
hbv
line
b
denv
line
b
peptid
known
present
b
b
respect
move
away
infer
hla
restrict
panel
b
lymphoblastoid
cell
line
consumpt
sampl
deriv
distinct
overlap
peptid
epitop
support
inform
fig
elisa
allow
us
rapidli
screen
abil
peptid
rescu
variou
hla
complex
denatur
sar
exampl
three
embed
peptid
restrict
either
b
fig
denv
hbv
antigen
found
least
one
peptid
set
stabil
hla
product
librari
mostli
bound
anticip
hla
support
inform
fig
often
posit
parent
peptid
fig
underscor
import
overlap
peptid
screen
approach
confirm
fine
specif
hla
restrict
curtail
list
peptid
tetram
stain
employ
sar
line
found
peptid
ie
getalall
getalalll
stabil
b
fig
yet
cell
line
stain
posit
b
tetram
load
fig
frequent
observ
extens
contract
singl
amino
detriment
hla
bind
peptid
yet
optim
epitop
recogn
correspond
tcr
expand
denv
hbv
line
stain
correspond
b
b
b
tetram
fig
pbmc
unrel
control
fig
sar
hbv
line
peptid
preselect
elisa
fail
yield
function
stain
reagent
comprehens
tetram
screen
truncat
peptid
howev
reveal
sitaqpvki
flgpllvlqa
optim
antigen
present
b
c
respect
seven
character
epitop
tabl
cell
bound
hla
counterpart
moder
affin
judg
mfi
shift
individu
tetram
b
hbv
hbv
display
c
provid
stain
cell
clearli
resolv
main
popul
function
line
establish
product
surfac
express
upon
peptid
stimul
confirm
result
fig
deliber
chose
employ
bioinformat
predict
select
candid
antigen
even
though
adopt
commonplac
curiou
assess
whether
algorithm
could
reproduc
outcom
discoveri
effort
select
netmhcpan
abil
comput
bind
capabl
peptid
even
hla
product
experiment
data
scarc
ii
accommod
epitop
variabl
length
iii
publicli
access
perform
predict
possibl
epitop
encompass
hbv
denv
peptid
hla
variant
donor
genotyp
data
inclus
impos
nm
affin
threshold
less
stringent
convent
cutoff
nm
provid
estim
specif
sensit
peptid
rank
valu
experiment
deriv
epitop
rank
determin
within
complet
hla
constel
pbmc
donor
well
correct
restrict
element
tabl
even
liber
strategi
would
instantli
preclud
discoveri
two
novel
epitop
peptid
sitaqpvki
flgpllvlqa
predict
bind
respect
valu
fold
cutoff
moreov
predict
misguid
flgpllvlqa
predict
affin
nm
true
restrict
element
nm
would
exclud
consider
given
predict
method
aim
reduc
magnitud
peptid
collect
investig
full
bioinformat
screen
encompass
peptid
overlap
peptid
librari
scenario
total
number
peptid
screen
netmhcpan
would
equal
collect
elispot
screen
ie
peptid
hbv
peptid
peptid
denv
condit
tetram
reagent
develop
compris
differ
hla
molecul
includ
report
therefor
number
highest
rank
peptid
screen
per
hla
hbv
eight
denv
follow
criteria
three
seven
novel
epitop
would
discov
base
rank
ie
sitaqpvki
sviwmmwyw
flgpllvlqa
tabl
netmhcpan
algorithm
would
employ
curtail
peptid
collect
half
size
elispot
screen
peptid
screen
per
hla
would
nine
hbv
four
denv
major
novel
antigen
ie
mevtpsgtwl
sitaqpvki
sviwmmwyw
flgpllvlqa
would
miss
although
method
might
well
outperform
individu
predict
submit
employ
netmhcpan
appropri
strategi
pbmc
donor
cohort
high
hla
polymorph
particularli
popul
preponder
class
hla
variant
limit
experiment
verifi
data
avail
expos
current
limit
deploy
predict
algorithm
valid
approach
use
overlap
peptid
librari
togeth
tetram
screen
identifi
character
novel
epitop
monitor
cellular
immun
respons
requir
disentangl
heterogen
basi
variou
diagnost
therapeut
applic
condit
ligand
integr
use
multim
array
flow
cytometr
analysi
cell
allow
rapid
synthesi
mhc
molecul
distinct
specif
protocol
strategi
appli
screen
class
antigen
sought
extend
technolog
specif
asian
popul
therefor
design
synthes
sensit
condit
ligand
construct
correspond
hla
molecul
thu
expand
portfolio
condit
hla
nearli
threefold
first
time
includ
allel
variant
despit
polymorph
natur
hla
librari
includ
major
allel
asia
fig
world
popul
region
stabil
complex
valid
hla
variant
prove
cooper
ligand
replac
fig
correspond
tetram
could
also
detect
common
respons
healthi
volunt
fig
identif
novel
epitop
asian
hla
variant
combin
elispot
condit
assay
ie
elisa
hla
tetram
array
therebi
build
key
featur
technolog
afford
circumv
limit
elispot
assay
quantifi
activ
secret
cytokin
recogn
high
sensit
compar
assay
assay
intracellular
cytokin
stain
also
permit
screen
pool
overlap
peptid
usag
clinic
sampl
econom
lymphocyt
maintain
viabil
make
amen
antigen
screen
ongo
epitop
identif
effort
hbv
denv
infect
identifi
seven
peptid
capabl
stimul
respons
singaporean
donor
fig
hla
restrict
fine
specif
epitop
would
commonli
infer
cellular
assay
howev
suffer
simultan
express
variou
hla
variant
complic
data
interpret
use
cage
asian
hla
measur
recept
accommod
shorter
peptid
embed
parent
antigen
rapidli
pinpoint
like
antigen
sequenc
util
low
amount
hla
reagent
spare
preciou
pbmc
sampl
ultim
confirm
peptid
fine
specif
hla
restrict
element
respons
engend
respons
provid
stain
array
hla
tetram
allow
rapid
visual
quantif
vitro
cultur
cryopreserv
sampl
freshli
isol
cell
high
specif
sensit
hla
tetram
thu
permit
monitor
isol
lymphocyt
usag
extend
screen
novel
antigen
seven
seven
time
antigen
epitop
correctli
identifi
valid
approach
reduc
number
epitop
biophys
mean
construct
hla
librari
give
suffici
coverag
epitop
screen
asia
probabl
match
hla
profil
lymphocyt
donor
least
one
cage
hla
high
sea
well
close
relat
popul
oceania
contrast
european
north
american
region
equival
molecul
alreadi
design
similar
effort
africa
southwest
asia
hla
divers
pronounc
would
need
suit
reagent
proport
extend
final
found
retrospect
analysi
bioinformat
strategi
predict
epitop
would
like
fail
identifi
consider
portion
novel
epitop
describ
herein
advanc
cytometri
compel
hla
tetram
technolog
keep
pace
equival
improv
higher
dimension
stain
distinct
subset
becom
feasibl
label
hla
multim
uniqu
combinatori
code
pass
cell
microarray
platform
inspect
emerg
technolog
label
cell
surfac
marker
heavi
metal
ion
cytof
analysi
among
advantag
elimin
need
fluoresc
compens
enabl
simultan
immunophenotyp
track
larg
cellular
subset
variou
patholog
immun
strongli
correl
protect
explor
therapeut
valu
warrant
increasingli
met
clinic
success
redirect
cell
target
viral
infect
malign
cell
may
gener
either
vitro
expans
autolog
lymphocyt
genet
modif
drive
tcr
express
desir
specif
infus
patient
develop
reli
accur
definit
respons
hla
librari
asian
variant
report
essenti
character
enumer
clinic
relev
cell
condit
ligand
manual
construct
standard
peptid
synthesi
deprotect
amino
acid
side
chain
releas
resin
achiev
trifluoroacet
acid
water
triisopropyl
silan
follow
precipit
cold
diethyl
ether
peptid
ident
confirm
lcm
analysi
shimadzu
peptid
use
screen
suppli
crude
lyophil
form
mimotop
suppli
lyophil
form
puriti
genscript
dissolv
dimethyl
sulfoxid
milliq
water
contain
mm
tri
phosphin
store
hla
product
produc
describ
briefli
gene
escherichia
coli
support
inform
tabl
plasmid
encod
human
chain
synthes
genscript
heavi
chain
contain
overexpress
e
coli
upon
isopropyl
induct
protein
isol
inclus
bodi
denatur
urea
solubil
heavi
light
chain
mix
molar
excess
condit
ligand
h
dialyz
mm
buffer
ph
concentr
enzymat
biotinyl
bira
hla
monom
purifi
chromatographi
conjug
molar
ratio
hla
tetram
dilut
pb
contain
replac
peptid
follow
long
wave
nm
uv
exposur
ultraviolet
uvp
h
incub
tetram
centrifug
rpm
supernat
use
cell
stain
condit
ligand
exchang
replac
peptid
hla
tetram
gener
concentr
follow
establish
protocol
micropl
corn
coat
streptavidin
invitrogen
pb
h
wash
two
percent
bsa
pb
ad
incub
min
room
temperatur
rt
peptid
exchang
initi
min
uv
irradi
perform
tube
contain
peptid
recombin
hla
pb
solut
dilut
nm
hla
ad
well
incub
h
plate
wash
tween
pb
antibodi
clone
abcam
ad
follow
h
incub
plate
wash
abt
solut
invitrogen
ad
min
develop
rt
reaction
stop
sodium
azid
citric
acid
absorb
nm
measur
use
spectramax
molecular
devic
approv
studi
protocol
conform
principl
set
wma
declar
helsinki
nih
belmont
report
provid
institut
review
board
nation
univers
singapor
healthi
volunt
recruit
written
inform
consent
blood
donat
suitabl
collect
pbmc
isol
fresh
heparin
blood
centrifug
cell
cultur
human
ab
serum
invitrogen
autolog
plasma
rpmi
media
contain
mm
invitrogen
supplement
iuml
penicillinstreptomycin
invitrogen
antigen
peptid
ad
uml
r
system
inc
ad
day
poststimul
half
media
chang
supplement
done
everi
day
line
hbv
core
obtain
previou
studi
hbv
hbv
line
denv
denv
line
develop
follow
line
grown
frozen
pbmc
previous
stimul
peptid
restimul
puls
media
h
cell
cultur
feeder
pbmc
b
cell
medium
invitrogen
pool
human
ab
serum
supplement
uml
ngml
ngml
r
system
day
line
upregul
produc
h
peptid
stimul
use
epitop
character
cell
obtain
donor
recruit
previou
studi
enrich
cell
pbmc
puls
gqggsptam
h
rt
medium
lonza
without
serum
afterward
cell
cultur
human
serum
cellsml
incub
ad
total
concentr
uml
peprotech
follow
day
cell
cultur
day
pbmc
wash
pb
cell
viabil
ascertain
fixabl
stain
invitrogen
prior
tetram
stain
cell
wash
stain
hla
tetram
pb
sodium
azid
ice
min
cell
subsequ
stain
clone
bd
bioscienc
clone
bd
bioscienc
min
wash
fix
paraformaldehyd
pb
cell
donor
stain
concentr
hla
tetram
min
follow
addit
antibodi
mix
consist
fluor
clone
biolegend
clone
respect
bd
clone
serotech
viabil
marker
fixabl
stain
invitrogen
min
data
acquir
bd
lsrii
flow
cytomet
bd
bioscienc
analyz
use
flowjo
treestar
inc
support
inform
fig
display
gate
strategi
appli
cell
grown
rpmi
invitrogen
supplement
pool
human
ab
serum
invitrogen
antibodi
clone
bd
bioscienc
brefeldin
ad
follow
stimul
peptid
mix
ngml
pma
ngml
ionomycin
h
cell
wash
hla
tetram
stain
perform
intracellular
cytokin
stain
done
use
antibodi
clone
r
system
human
intracellular
cytokin
stain
starter
kit
bd
bioscienc
accord
manufactur
specif
algorithm
use
predict
valu
peptid
found
proteom
hbv
denv
includ
core
x
envelop
polymeras
protein
hbv
genotyp
b
ncbi
access
well
hbv
genotyp
b
ncbi
access
hbv
genotyp
c
ncbi
access
envelop
protein
furthermor
capsid
membran
glycoprotein
envelop
protein
protein
k
peptid
denv
ncbi
access
np
protein
ncbi
access
includ
predict
made
allel
per
donor
output
peptid
affin
threshold
nm
enabl
rank
author
declar
financi
commerci
conflict
interest
